Posts Tagged ‘FDA’

Medical roundup

  • “Apple Watch can detect an early sign of heart disease…. Apple has been communicating privately with the FDA for years about medical devices and so far the FDA has taken a light touch to Apple but these issues are coming to a head.” [Tyler Cowen]
  • “[Investor] lawsuits targeting life sciences firms jumped 70 percent from 2014, according to a survey provided earlier this year by Dechert.” [Amanda Bronstad, New York Law Journal]
  • Iowa Gov. Terry Branstad signs medical malpractice reforms into law [Brianne Pfannenstiel, Des Moines Register]
  • Summing up what is known re: talc and ovarian cancer as background to jury’s $105 million verdict against Johnson & Johnson [BBC (in story’s second half), earlier here, here, and here]
  • $5,300 for an MRI that would cost Medicaid $500? Personal attendants for crash victims, even the ones well enough to participate in mixed martial arts? All part of Michigan no-fault crash system [Detroit Free Press investigative series, see yesterday’s post]
  • Dear D.C.: ditch the FDA deeming regs and let vaping save smokers’ lives [Jeff Stier/Henry Miller, NRO, Tony Abboud/The Hill (vaping trade association), Juliet Eilperin/Washington Post (FDA temporarily suspends enforcement)]

Food roundup

Medical roundup

  • Scott Gottlieb likely to steer FDA in right direction [Daniel Klein]
  • Study of shorter versus longer medical consent forms “finds no significant difference in comprehension, satisfaction, enrollment” [Grady et al., PLOS via Michelle Meyer]
  • C’mon, ACLU and Covington: “Lawsuit Aims to Force Catholic Hospitals Perform Transgender-Related Surgeries” [Scott Shackford]
  • So much: “What The New York Times Gets Wrong On Vaping Regulation” [Sally Satel]
  • “Should you be compensated for your medical waste, especially if it turns out to be valuable? The right answer is: no.” [Ronald Bailey, Reason on Henrietta Lacks story]
  • Kimberly-Clark: we’ve sold 70 million MicroCool hospital gowns without a single complaint of injury from alleged permeability. Calif. jury: that’ll be $454 million [Insurance Journal]

Medical roundup

Food and Drug Administration roundup

Medical roundup

  • “Judge Says He’s Had Enough Of Weeding Through Baseless Lawsuits, Threatens Sanctions” [Daniel Fisher; M. D. Georgia judge on vaginal mesh cases]
  • More on pricey regulated generics [Scott Gottlieb/WSJ, earlier on EpiPen, more on latter from Joel Zinberg/City Journal]
  • Feds ban pre-dispute arbitration agreements in nursing home care [McKnights]
  • How Ronald Reagan’s FDA responded to the AIDS crisis — and it’s probably not the story you’ve heard [Peter Huber, City Journal; see also from Carl Cannon in 2014]
  • FDA regs likely to winnow smaller, distinctive makers from the cigar business, recalling a Somerset Maugham story [James M. Patterson] Debunking the “Helena miracle,” once more: no link between local smoking bans and short-term drops in heart attacks [Jacob Sullum, earlier here and here]
  • “Ethicists make the case for bone marrow transplantation markets” [Ilya Somin]

“The FDA cultivates a coterie of journalists whom it keeps in line with threats”

Charles Seife in Scientific American tells the story of how, using the “close-hold embargo” and other techniques, the Food and Drug Administration (FDA) and other government agencies shape what you read about them when major initiatives and findings are announced. I sum up highlights in my new Cato post. More: Megan McArdle.

Medical roundup

  • FDA to dental consumers: you can’t handle the tooth [New York Times via Alex Tabarrok]
  • “How lawyers scare people out of taking their meds” [Lisa Rickard (U.S. Chamber), Washington Post]
  • Lawsuits fail to bring improvements to nursing homes [ABA Journal]
  • Everything,” new Institute for Justice short film about costs of regulating bone marrow donation, has upcoming screenings in D.C. area, Breckinridge, Colo. and elsewhere;
  • Aetna pulls out of most ObamaCare exchanges, and the acrimony flies [WSJ editorial] “Did the Medicaid expansion limit labor force participation?” [Tomas Wind via Tyler Cowen]
  • Posting will be slower in coming weeks as I conduct my own in-person investigation of the state of America’s medical system. Thanks for bearing with me!

“Scott Alexander” on the EpiPen affair

“When was the last time that America’s chair industry hiked the price of chairs 400% and suddenly nobody in the country could afford to sit down?” Funny, isn’t it, how these episodes keep happening in a sector of the economy where a new competitor, before being allowed to enter even a well-understood generic market, faces the prospect of unpredictable and expensive government denials and delays? [Scott Alexander]

More: Scott Gottlieb on how the new, more ardently regulatory FDA keeps generic drugs (and devices) off the market. Don’t blame the patent angle; EpiPen is off-patent [Timothy Holbrook, The Conversation]

Food and nanny state roundup

  • Has Obama administration endorsed anti-GMO campaign with new labeling law? Not really [Thomas Firey, Cato, earlier here, here, etc.]
  • United Nations anti-tobacco meeting seeks to exclude persons overly involved with tobacco production, ban list turns out to include many officials of member governments [Huffington Post UK]
  • Dumping Michigan tart cherries to comply with USDA marketing order? There must be a better way [Baylen Linnekin]
  • “I am the man, the very fat man, who waters the workers’ beer.” [Science Daily, prompting Christopher Snowdon’s recollection of that line of song]
  • Feds alone have spent $500 million chasing food-desert mirage, with “negligible” impact on health [Mac McCann, Dallas News, earlier]
  • “FDA Assigns Zero Value To Smokers Who Die Because Of Its E-Cigarette Regulations” [Jacob Sullum, more on vaping]